Welcome to Five Easy Questions with Maddy Grace where we explain the public markets and the companies that trade on them. In today’s episode, Maddy speaks with Ben Lightburn,…
Psychedelics
BetterLife Pharma (BETR.CN) is a Biotech company focused on developing second generation psychedelic compounds and nutraceuticals. Their products will address the unmet needs in the mental health, wellness and…
Brew yourself a cup of coffee before diving into this weeks Agriculture sector round up. No seriously. Brew that cup of coffee. I am changing things around this week….
Revive Therapeutics (RVV.C) joined the AdvisorShares Psychedelics ETF (PSIL.NYSE) today, in time for its launch, according to a press release. If you’re not entirely sure what an ETF…
Filament Health (FH.NEO) got the nod from the Financial Regulatory Authority to start trading on the OTC Pink Market in the United States under the symbol “FLHLF,” and has…
Filament Health (FH.NEO) filed their 20th patent application for their research phase programs, including three international Patent Cooperation Treaty (PCT) applications, earlier this week, according to a press release….
Red Light Holland (TRIP.C) and Australian-based cannabis company, Creso Pharma Limited (CPH.ASX) cancelled their previously announced merger today, according to a press release. The merger was originally announced…
Filament Health (FH.NE) shipped their first batch of good manufacturing practices (GMP) certified natural psilocybin into the United States earlier this week, according to a press release. The…
Braxia Scientific (BRAX.C) announced they will be conducting a randomized clinical trial that will involve giving patients multiple doses of psilocybin. Braxia says this is Canada’s first psilocybin trial…
Another busy week in the psychedelic sector, with many smaller companies not always covered here at Equity Guru making news. Let’s start with the biggest players though. Mind Medicine…